Dublin, April 06, 2016 -- Research and Markets has announced the addition of the "Global Smart Phone Enabled Healthcare Diagnostics Market Assessment & Forecast 2016 - 2020" report to their offering.
The report focuses on this highly prospective market across six regions of North America, Europe, Asia-Pacific, Latin-America, Middle-East and Africa.
The market varies from region to region based on several factors, such as adoption of smart phone among medical community as well as patients, internet and broadband services, investment into digital health by foreign investors as well as encouragement by the National authorities. Thus, the analysis applies a thorough PESTLE (political, economic, social, technological, legal and environmental) understanding to conclude the estimations of the market by region.
This report also focuses on applications of smart phone based diagnostics in all medical specialties and provides emphasis on six major areas where smart phone enabled healthcare diagnostics have been developed through the last few years. They are cardiovascular, hematology (related to blood analysis), respiratory, obstetrics & gynecology, dermatology, Ophthalmology and Others. Applications include devices offered by notable players throughout the world. Due to the budding nature of this market, the report estimates devices and systems that are approved by federal and regional authorities such as FDA and CE as well as those not approved but commercially active on the market.
Cardiovascular and hematological were the most popular applications targeted by innovators. Devices introduced to focus on diseases and conditions encompassing these two segments target the largest populations across the world. Lifestyle disorders such as obesity along with several other conditions such as diabetes are affecting millions of people across the world. In 2015 cardiology based smart phone enabled diagnostics accounted for the largest share of 31.5%.
Hardware, software and services include devices performing on microfluidics, microelectromechanical technology, spectrophotometry along with other imaging and photonics technologies.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Précis
Chapter 3 Market Dynamics
Chapter 4 Smart Phone Enabled Healthcare Diagnostics Market - Global Market Size Assessment, by Hardware, Forecast: 2016 - 2020
Chapter 5 Smart Phone Enabled Healthcare Diagnostics Market - Global Market Size Assessment, by Software, Forecast: 2016 - 2020
Chapter 6 Smart Phone Enabled Healthcare Diagnostics Market - Global Market Size Assessment, by Services, Forecast: 2016 - 2020
Chapter 7 Smart Phone Enabled Healthcare Diagnostics Market - Global Market Size Assessment, by Applications, Forecast: 2016 - 2020
Chapter 8 Smart Phone Enabled Healthcare Diagnostics - Global Market Size Assessment, by Geography, Forecast: 2016 - 2020
Chapter 9 Key Players Analysis: Smart Phone Enabled Healthcare Diagnostics Market, 2015
Chapter 10 Epilogue
Companies Mentioned
- AirStrip Technologies.
- AkibaH Inc.
- AliveCor
- Calgary Scientific
- CellScope
- Cerora
- DexCom
- Entra Health
- Everist Health
- EyeNetra
- Gentag
- Glooko Inc
- Hera Med
- Holomic LLC (now CellMic)
- iHealth
- LabStyle Innovations
- LifeScan
- LifeWatch Technologies
- McKesson Israel ltd
- Medtronic Inc
- Mega Electronics
- MobileODT
- Mobisante
- Nonin
- OJ-Bio
- Personal MedSystems GmbH
- Philips Healthcare
- Samsung
- Scanadu
- Shanghai Berry Electronic Tech Co.Ltd
- SHL Telemedicine
- Sonostar Technologies Co.Limited (China)
- Welch Allyn
For more information visit http://www.researchandmarkets.com/research/63ph2m/global_smart
CONTACT: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Diagnostics